US Generics Players Enjoy Calmer Waters
After Some Tumultuous Years, Pressures In The US Market Have Eased In Recent Quarters
After years of heavy price and cost pressures that have taken a toll on firms operating in the US generics market, more recent quarters appear to have reflected a calmer and more predictable landscape.
